logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 8652 352524; +7 8652 353229.

Fax
+7 8652 352524.

E-mail
medvestnik@stgmu.ru

The effect of type 2 diabetes mellitus on the course of chronic obstructive pulmonary disease

[Internal diseases]
Andrei Budnevskiy; Natalia Polyakova; Evgeniy Ovsyannikov; Zarema Alimkhanova;

This article reviews the results of a comparative analysis of 80 cases of patients with chronic obstructive pulmonary disease (COPD). Of these, 40 cases of patients with comorbid pathology (COPD and type 2 diabetes mellitus) and 40 cases of COPD patients without type 2 diabetes. The data of questionnaires, tests, clinical and laboratory and instrumental indicators were analyzed. There was demonstrated negative role of type 2 diabetes on the course of COPD by such indicators as the frequency of exacerbation of COPD per year, the frequency of calls of ambulance team, the frequency of hospitalizations for exacerbation or deterioration of the course of COPD, clinical symptoms of COPD, spirometry parameters and cytokine and adipocytokine profiles.

Download

References:
1. Chuchalin A. G., Avdeyev S. N., Aysanov Z. R., Belevsky A. S., Leshchenko I. V. [et al.]. Russian Respiratory Society: Federal clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease. Pulmonologiya. – Pulmonology. 2014;3:15-54. (In Russ.).
2. Gajnitdinova V. V., Avdeev S. N. Chronic obstructive pulmonary disease with pulmonary hypertension: features of the course, survival rate, predictors of mortality. Pulmonologiya. – Pulmonology. 2017;27(3):357-365. (In Russ.).
3. Gelcer B. I., Kurpatov I. G., Kotelnikov V. N., Zajac Ju. V. Chronic obstructive pulmonary disease and cerebrovascular diseases: structural-functional and clinical aspects of comorbidity. Terapevticheskiy arhiv. – Therapeutic archive. 2018;90(3):81-88. (In Russ.).
4. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2017.
5. Kobyljanskij V. I., Babadzhanova G. Ju., SuncovJu. I. Study of links between chronic obstructive pulmonary disease, asthma and type 2 diabetes mellitus. Klinicheskaya medicina. – Сlinical medicine. 2009;87(12):40-43. (In Russ.).
6. Cazzola M., Calzetta L., Rogliani P., Lauro D., Novelli L. [et al.]. High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway. Am. J. Respir. Cell. Mol. Biol. 2012;47(4):509-516.
7. Hersh C. P., Make B. J., Lynch D. A., Barr R. G., Bowler R. P. [et al.]. and the COPD Gene and ECLIPSE Investigators. Non-emphysematous COPD is associated with diabetes. BMC Pulmonary Medicine. 2014;14:164- 169.
8. Мiravitlles M., Soler-Cataluña J. J., Calle M., Soriano J. B. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur. Respir. J. 2013;41(12):52-56.
9. Surkova E. A., Kuzubova N. A., Ses T. P., Totolyan Areg A. Features of cytokine regulation of focal and systemic inflammation in COPD. Meditsinskaya immunologiya. – Medical immunology. 2010;12(4-5):349-354. (In Russ.).
10. Rogliani P., CalzettaL., Segreti A., Barrile A., Cazzola M. Diabetes among outpatients with COPD attending a university hospital. Acta Diabetologica. 2014;51(6):933- 940.
11. Dedov I. I., Shestakova M. V., Mayorov A. Y. Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol’nym sakharnym diabetom. M.: «UPPRINT»; 2017. (In Russ.).

Keywords: chronic obstructive pulmonary disease, type 2 diabetes mellitus, cytokine, adipocytokine, quality of life


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy